https://orcid.org/0000-0002-7420-4394
Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Ginette S. Santiago-Sánchez, Kellsye P. Fabian & James W. Hodge. (2024) A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance. Cancer Biology & Therapy 25:1.
Read now
Read now
Albert Jang, Sree M. Lanka, Hui Ting Ruan, Hamsa L.S. Kumar, Angela Y. Jia, Jorge A. Garcia, Omar Y. Mian & Pedro C. Barata. (2023) Novel therapies for metastatic prostate cancer. Expert Review of Anticancer Therapy 23:12, pages 1251-1263.
Read now
Read now
Oliver Kepp, Giulia Cerrato, Allan Sauvat & Guido Kroemer. (2022) Nanoparticles releasing immunogenic cell death inducers upon near-infrared light exposure. OncoImmunology 11:1.
Read now
Read now
Oliver Kepp & Guido Kroemer. (2022) A nanoparticle-based tour de force for enhancing immunogenic cell death elicited by photodynamic therapy. OncoImmunology 11:1.
Read now
Read now
Peng Liu, Jianzhou Chen, Liwei Zhao, Antoine Hollebecque, Oliver Kepp, Laurence Zitvogel & Guido Kroemer. (2022) PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer. OncoImmunology 11:1.
Read now
Read now
Oliver Kepp, Lucillia Bezu & Guido Kroemer. (2022) The endoplasmic reticulum chaperone BiP: a target for immunogenic cell death inducers?. OncoImmunology 11:1.
Read now
Read now
Julie Le Naour, Zsofia Sztupinszki, Vincent Carbonnier, Odile Casiraghi, Virginie Marty, Lorenzo Galluzzi, Zoltan Szallasi, Guido Kroemer & Erika Vacchelli. (2022) A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients. OncoImmunology 11:1.
Read now
Read now
Kamal S Saini, Kevin Punie, Chris Twelves, Stefanella Bortini, Evandro de Azambuja, Steven Anderson, Carmen Criscitiello, Ahmad Awada & Sherene Loi. (2021) Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics. Expert Opinion on Biological Therapy 21:7, pages 945-962.
Read now
Read now
Juliette Humeau, Julie Le Naour, Lorenzo Galluzzi, Guido Kroemer & Jonathan G. Pol. (2021) Trial watch: intratumoral immunotherapy. OncoImmunology 10:1.
Read now
Read now
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer & Erika Vacchelli. (2020) Trial watch: IDO inhibitors in cancer therapy. OncoImmunology 9:1.
Read now
Read now
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer & Erika Vacchelli. (2020) Trial watch: TLR3 agonists in cancer therapy. OncoImmunology 9:1.
Read now
Read now
Oliver Kepp & Guido Kroemer. (2020) A novel platinum-based chemotherapeutic inducing immunogenic cell death. OncoImmunology 9:1.
Read now
Read now
Articles from other publishers (66)
Hui Pan, Peng Liu, Liwei Zhao, Yuhong Pan, Misha Mao, Guido Kroemer & Oliver Kepp. (2024) Immunogenic cell stress and death in the treatment of cancer. Seminars in Cell & Developmental Biology 156, pages 11-21.
Crossref
Crossref
Gaidaa M. Dogheim, Nourhan E. El Feel, Esraa A. Abd El-Maksod, Sandra Sh. Amer, Sanaa A. El-Gizawy, Ahmed S. Abd Elhamid & Ahmed O. Elzoghby. (2024) Nanomedicines as enhancers of tumor immunogenicity to augment cancer immunotherapy. Drug Discovery Today 29:3, pages 103905.
Crossref
Crossref
Suxing Jin, Yan Guo & Xiaoyong Wang. (2024) Development of Platinum Complexes for Tumor Chemoimmunotherapy. Chemistry – A European Journal 30:10.
Crossref
Crossref
Hui Pan, Peng Liu, Guido Kroemer & Oliver Kepp. 2024. Immune Checkpoint Biology in Health and Disease. Immune Checkpoint Biology in Health and Disease
279
294
.
Liling Qin & Jianan Wu. (2023) Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles. Environmental Research 239, pages 116751.
Crossref
Crossref
Paul D. O'Dowd, Darragh F. Sutcliffe & Darren M. Griffith. (2023) Oxaliplatin and its derivatives – An overview. Coordination Chemistry Reviews 497, pages 215439.
Crossref
Crossref
Amrita Sarkar, Vojtech Novohradsky, Moumita Maji, Tomer Babu, Lenka Markova, Hana Kostrhunova, Jana Kasparkova, Valentina Gandin, Viktor Brabec & Dan Gibson. (2023) Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death. Angewandte Chemie International Edition 62:42.
Crossref
Crossref
Amrita Sarkar, Vojtech Novohradsky, Moumita Maji, Tomer Babu, Lenka Markova, Hana Kostrhunova, Jana Kasparkova, Valentina Gandin, Viktor Brabec & Dan Gibson. (2023) Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death. Angewandte Chemie 135:42.
Crossref
Crossref
Xiao-Dong Wang, Jia-Xin Wang & Ming-Hao Hu. (2023) Novel phenanthrene imidazoles as telomeric G-quadruplex ligands trigger potent immunogenic cell death in triple-negative breast cancer. International Journal of Biological Macromolecules 249, pages 126068.
Crossref
Crossref
Sihui Yu, Hongyang Xiao, Li Ma, Jiawen Zhang & Jiarong Zhang. (2023) Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:5, pages 188946.
Crossref
Crossref
Lan-Shan Liao, Yin Chen, Cheng Hou, Yang-Han Liu, Gui-Fa Su, Hong Liang & Zhen-Feng Chen. (2023)
Potent Zinc(II)-Based Immunogenic Cell Death Inducer Triggered by ROS-Mediated ERS and Mitochondrial Ca
2+
Overload
. Journal of Medicinal Chemistry 66:15, pages 10497-10509.
Crossref
Crossref
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P. Gonzalez-Rodriguez, Alejandra Martínez-Pérez, Juan P. Rodrigo, Juana M. García-Pedrero & Segundo Gonzalez. (2023) Chemo-Immunotherapy: A New Trend in Cancer Treatment. Cancers 15:11, pages 2912.
Crossref
Crossref
Lingpu Zhang, Nicolás Montesdeoca, Johannes Karges & Haihua Xiao. (2023) Immunogenic Cell Death Inducing Metal Complexes for Cancer Therapy. Angewandte Chemie International Edition 62:21.
Crossref
Crossref
Lingpu Zhang, Nicolás Montesdeoca, Johannes Karges & Haihua Xiao. (2023) Immunogenen Zelltod induzierende Metallkomplexe für die Krebstherapie. Angewandte Chemie 135:21.
Crossref
Crossref
Agnes Ducoulombier, Joel Guigay, Marie-Christine Etienne-Grimaldi & Esma Saada-Bouzid. (2023) Chemotherapy postimmunotherapy for recurrent metastatic head and neck squamous cell carcinoma. Current Opinion in Oncology 35:3, pages 166-177.
Crossref
Crossref
Fukang Shi, Xing Huang, Zhengtao Hong, Na Lu, Xin Huang, Lingyue Liu, Tingbo Liang & Xueli Bai. (2023) Improvement strategy for immune checkpoint blockade: A focus on the combination with immunogenic cell death inducers. Cancer Letters 562, pages 216167.
Crossref
Crossref
Zhaoyun Liu, Xintong Xu, Kaining Liu, Jingtian Zhang, Dan Ding & Rong Fu. (2023) Immunogenic Cell Death in Hematological Malignancy Therapy. Advanced Science 10:13.
Crossref
Crossref
Jiaqi Zhai, Xi Gu, Yang Liu, Yueting Hu, Yi Jiang & Zhenyong Zhang. (2023) Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review. Frontiers in Pharmacology 14.
Crossref
Crossref
Rohan Maniar & Patrick J. LoehrerSr.Sr.. (2023) Understanding the landscape of immunotherapy in thymic epithelial tumors. Cancer 129:8, pages 1162-1172.
Crossref
Crossref
Yinan Wu, Xiaonan Gong, Kaiyue Wang, Chengcheng Yu, Jili Qiu, Suzhan Zhang, Yue Hu & Kaimin Hu. (2023) Neoadjuvant Endocrine Therapy: A Potential Way to Make Cold
Hormone Receptor-Rich Breast Cancer Hot. Combinatorial Chemistry & High Throughput Screening 26:5, pages 1030-1041.
Crossref
Crossref
Sajal Sen, Krystle Karoscik, Esther Maier & Jonathan F. Arambula. (2023) Immunogenic cell death-inducing metal complexes: From the benchtop to the clinic. Current Opinion in Chemical Biology 73, pages 102277.
Crossref
Crossref
Jianing Liu, Yi Cao, Bin Hu, Tao Li, Wei Zhang, Zhongze Zhang, Jinhua Gao, Hanjing Niu, Tengli Ding, Jinzhong Wu, Yutong Chen, Pengfei Zhang, Ruijuan Ma, Shihao Su, Chaojie Wang, Peng George Wang, Jing Ma & Songqiang Xie. (2023) Older but Stronger: Development of Platinum-Based Antitumor Agents and Research Advances in Tumor Immunity. Inorganics 11:4, pages 145.
Crossref
Crossref
Xiaolin Xiong, Yuan Wang & Taotao Zou. (2022) Towards Understanding the Molecular Mechanisms of Immunogenic Cell Death. ChemBioChem 24:6.
Crossref
Crossref
Lorenzo Galluzzi, Oliver Kepp, Erik Hett, Guido Kroemer & Francesco M. Marincola. (2023) Immunogenic cell death in cancer: concept and therapeutic implications. Journal of Translational Medicine 21:1.
Crossref
Crossref
Jaron Mark, Dan T. Fisher, Minhyung Kim, Tiffany Emmons, A.N.M. Nazmul Khan, Emad Alqassim, Kelly Singel, Anna Mistarz, Amit Lugade, Haiying Zhan, Han Yu, Brahm Segal, Shashikant Lele, Peter Frederick, Danuta Kozbor, Joseph Skitzki & Kunle Odunsi. (2023) Carboplatin enhances lymphocyte-endothelial interactions to promote CD8+ T cell trafficking into the ovarian tumor microenvironment. Gynecologic Oncology 168, pages 92-99.
Crossref
Crossref
Xiaokai Zhang, Jie Wen, Guixiong Zhang, Wenzhe Fan, Jizhou Tan, Haikuan Liu & Jiaping Li. (2023) Identification and Validation of Novel Immunogenic Cell Death- and DNA Damage Response-Related Molecular Patterns Correlated with Immune Status and Prognosis in Hepatocellular Carcinoma. Translational Oncology 27, pages 101600.
Crossref
Crossref
Xingyu Chang, Mianli Bian, Lijuan Liu, Jiaqi Yang, Zhibin Yang, Zhaoran Wang, Yunlong Lu & Wukun Liu. (2023) Induction of immunogenic cell death by novel platinum-based anticancer agents. Pharmacological Research 187, pages 106556.
Crossref
Crossref
Idoko Salifu, Navneet Singh, Maria Berraondo, Jordi Remon, Stephanie Salifu, Eric Severson, Angela Quintana, Sandra Peiró, Shakti Ramkissoon, Laura Vidal, Isagani Chico & Kamal S. Saini. (2023) Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in advanced non-small cell lung cancer. Cancer Treatment and Research Communications 36, pages 100713.
Crossref
Crossref
Juliette Humeau, Julie Le Naour, Guido Kroemer & Jonathan G. Pol. 2023.
Attila A. Seyhan & Claudio Carini. (2022) Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response Rates. International Journal of Molecular Sciences 24:1, pages 41.
Crossref
Crossref
Qing Li, Ting Liu & Zhenyu Ding. (2022) Neoadjuvant immunotherapy for resectable esophageal cancer: A review. Frontiers in Immunology 13.
Crossref
Crossref
Kellsye P. Fabian, Joshua T. Kowalczyk, Sandy T. Reynolds & James W. Hodge. (2022) Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation. Cells 11:23, pages 3826.
Crossref
Crossref
Deqian Xie, Qifei Wang & Guangzhen Wu. (2022) Research progress in inducing immunogenic cell death of tumor cells. Frontiers in Immunology 13.
Crossref
Crossref
Zahid H. Siddik. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
8
.
Ruth Soler-Agesta, Joaquín Marco-Brualla, Martha Minjárez-Sáenz, Christina Y. Yim, Marta Martínez-Júlvez, Matthew R. Price, Raquel Moreno-Loshuertos, Tyler D. Ames, José Jimeno & Alberto Anel. (2022) PT-112 Induces Mitochondrial Stress and Immunogenic Cell Death, Targeting Tumor Cells with Mitochondrial Deficiencies. Cancers 14:16, pages 3851.
Crossref
Crossref
Xinye Qian, Wang Hu & Jun Yan. (2022) Nano-Chemotherapy synergize with immune checkpoint inhibitor- A better option?. Frontiers in Immunology 13.
Crossref
Crossref
Yushu Wang, Bin Wang, Kao Li, Maosheng Wang & Haihua Xiao. (2022) Engineered metal and their complexes for nanomedicine-elicited cancer immunotherapy. Materials Today Advances 15, pages 100276.
Crossref
Crossref
Daniel D. Karp, D. Ross Camidge, Jeffery R. Infante, Tyler D. Ames, Matthew R. Price, José Jimeno & Alan H. Bryce. (2022) Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours. eClinicalMedicine 49, pages 101430.
Crossref
Crossref
Zhi‐Yuan Li, Qing‐Hua Shen, Zong‐Wan Mao & Cai‐Ping Tan. (2022) Rising Interest in the Development of Metal Complexes in Cancer Immunotherapy. Chemistry – An Asian Journal 17:13.
Crossref
Crossref
Xiaolin Xiong, Ke-Bin Huang, Yuan Wang, Bei Cao, Yunli Luo, Huowen Chen, Yan Yang, Yan Long, Moyi Liu, Albert S. C. Chan, Hong Liang & Taotao Zou. (2022) Target Profiling of an Iridium(III)-Based Immunogenic Cell Death Inducer Unveils the Engagement of Unfolded Protein Response Regulator BiP. Journal of the American Chemical Society 144:23, pages 10407-10416.
Crossref
Crossref
Jitka Fucikova, Lenka Palova-Jelinkova, Vanessa Klapp, Peter Holicek, Tereza Lanickova, Lenka Kasikova, Jana Drozenova, David Cibula, Beatriz Álvarez-Abril, Elena García-Martínez, Radek Spisek & Lorenzo Galluzzi. (2022) Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents. Trends in Cancer 8:5, pages 426-444.
Crossref
Crossref
André E. Nel, Kuo-Ching Mei, Yu-Pei Liao & Xiangsheng Liu. (2022) Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs. ACS Nano 16:4, pages 5184-5232.
Crossref
Crossref
Guido Kroemer, Claudia Galassi, Laurence Zitvogel & Lorenzo Galluzzi. (2022) Immunogenic cell stress and death. Nature Immunology 23:4, pages 487-500.
Crossref
Crossref
Sajal Sen, Miae Won, Matthew S. Levine, Yuvin Noh, Adam C. Sedgwick, Jong Seung Kim, Jonathan L. Sessler & Jonathan F. Arambula. (2022) Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future. Chemical Society Reviews 51:4, pages 1212-1233.
Crossref
Crossref
Andrea Palicelli, Stefania Croci, Alessandra Bisagni, Eleonora Zanetti, Dario De Biase, Beatrice Melli, Francesca Sanguedolce, Moira Ragazzi, Magda Zanelli, Alcides Chaux, Sofia Cañete-Portillo, Maria Paola Bonasoni, Stefano Ascani, Antonio De Leo, Guido Giordano, Matteo Landriscina, Giuseppe Carrieri, Luigi Cormio, Jatin Gandhi, Davide Nicoli, Enrico Farnetti, Simonetta Piana, Alessandro Tafuni & Martina Bonacini. (2022) What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other Genes. Biomedicines 10:2, pages 236.
Crossref
Crossref
Giulia Cerrato, Juliette Humeau, Allan Sauvat, Oliver Kepp & Guido Kroemer. 2022. Radiation Oncology and Radiotherapy Part A. Radiation Oncology and Radiotherapy Part A
67
82
.
Andrea Palicelli, Martina Bonacini, Stefania Croci, Alessandra Bisagni, Eleonora Zanetti, Dario De Biase, Francesca Sanguedolce, Moira Ragazzi, Magda Zanelli, Alcides Chaux, Sofia Cañete-Portillo, Maria Paola Bonasoni, Stefano Ascani, Antonio De Leo, Jatin Gandhi, Alessandro Tafuni & Beatrice Melli. (2021) What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 7: PD-L1 Expression in Liquid Biopsy. Journal of Personalized Medicine 11:12, pages 1312.
Crossref
Crossref
Samantha K. Von Rueden & Timothy M. Fan. (2021) Cancer-Immunity Cycle and Therapeutic Interventions- Opportunities for Including Pet Dogs With Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Andrea Palicelli, Stefania Croci, Alessandra Bisagni, Eleonora Zanetti, Dario De Biase, Beatrice Melli, Francesca Sanguedolce, Moira Ragazzi, Magda Zanelli, Alcides Chaux, Sofia Cañete-Portillo, Maria Paola Bonasoni, Alessandra Soriano, Stefano Ascani, Maurizio Zizzo, Carolina Castro Ruiz, Antonio De Leo, Guido Giordano, Matteo Landriscina, Giuseppe Carrieri, Luigi Cormio, Daniel M. Berney, Jatin Gandhi, Valerio Copelli, Giuditta Bernardelli, Giacomo Santandrea & Martina Bonacini. (2021) What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment. International Journal of Molecular Sciences 22:22, pages 12330.
Crossref
Crossref
Andrea Palicelli, Stefania Croci, Alessandra Bisagni, Eleonora Zanetti, Dario De Biase, Beatrice Melli, Francesca Sanguedolce, Moira Ragazzi, Magda Zanelli, Alcides Chaux, Sofia Cañete-Portillo, Maria Paola Bonasoni, Alessandra Soriano, Stefano Ascani, Maurizio Zizzo, Carolina Castro Ruiz, Antonio De Leo, Guido Giordano, Matteo Landriscina, Giuseppe Carrieri, Luigi Cormio, Daniel M. Berney, Jatin Gandhi, Davide Nicoli, Enrico Farnetti, Giacomo Santandrea & Martina Bonacini. (2021) What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1. International Journal of Molecular Sciences 22:22, pages 12314.
Crossref
Crossref
Andrea Palicelli, Stefania Croci, Alessandra Bisagni, Eleonora Zanetti, Dario De Biase, Beatrice Melli, Francesca Sanguedolce, Moira Ragazzi, Magda Zanelli, Alcides Chaux, Sofia Cañete-Portillo, Maria Paola Bonasoni, Alessandra Soriano, Stefano Ascani, Maurizio Zizzo, Carolina Castro Ruiz, Antonio De Leo, Guido Giordano, Matteo Landriscina, Giuseppe Carrieri, Luigi Cormio, Daniel M. Berney, Jatin Gandhi, Giacomo Santandrea & Martina Bonacini. (2021) What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models). International Journal of Molecular Sciences 22:22, pages 12297.
Crossref
Crossref
Andrea Palicelli, Martina Bonacini, Stefania Croci, Cristina Magi-Galluzzi, Sofia Cañete-Portillo, Alcides Chaux, Alessandra Bisagni, Eleonora Zanetti, Dario De Biase, Beatrice Melli, Francesca Sanguedolce, Moira Ragazzi, Maria Paola Bonasoni, Alessandra Soriano, Stefano Ascani, Maurizio Zizzo, Carolina Castro Ruiz, Antonio De Leo, Guido Giordano, Matteo Landriscina, Giuseppe Carrieri, Luigi Cormio, Daniel M. Berney, Daniel Athanazio, Jatin Gandhi, Alberto Cavazza, Giacomo Santandrea, Alessandro Tafuni & Magda Zanelli. (2021) What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables. Cells 10:11, pages 3166.
Crossref
Crossref
Andrea Palicelli, Martina Bonacini, Stefania Croci, Cristina Magi-Galluzzi, Sofia Cañete-Portillo, Alcides Chaux, Alessandra Bisagni, Eleonora Zanetti, Dario De Biase, Beatrice Melli, Francesca Sanguedolce, Magda Zanelli, Maria Paola Bonasoni, Loredana De Marco, Alessandra Soriano, Stefano Ascani, Maurizio Zizzo, Carolina Castro Ruiz, Antonio De Leo, Guido Giordano, Matteo Landriscina, Giuseppe Carrieri, Luigi Cormio, Daniel M. Berney, Jatin Gandhi, Giacomo Santandrea, Maria Carolina Gelli, Alessandro Tafuni & Moira Ragazzi. (2021) What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic–Pathologic Correlations. Cells 10:11, pages 3165.
Crossref
Crossref
Roman M. Chabanon, Mathieu Rouanne, Christopher J. Lord, Jean-Charles Soria, Philippe Pasero & Sophie Postel-Vinay. (2021) Targeting the DNA damage response in immuno-oncology: developments and opportunities. Nature Reviews Cancer 21:11, pages 701-717.
Crossref
Crossref
Katerina Spyridopoulou, Georgios Aindelis, Aglaia Pappa & Katerina Chlichlia. (2021) Anticancer Activity of Biogenic Selenium Nanoparticles: Apoptotic and Immunogenic Cell Death Markers in Colon Cancer Cells. Cancers 13:21, pages 5335.
Crossref
Crossref
Alessandra Barbanente, Rosa Maria Iacobazzi, Amalia Azzariti, James D. Hoeschele, Nunzio Denora, Paride Papadia, Concetta Pacifico, Giovanni Natile & Nicola Margiotta. (2021) New Oxaliplatin-Pyrophosphato Analogs with Improved In Vitro Cytotoxicity. Molecules 26:11, pages 3417.
Crossref
Crossref
Ilio Vitale, Takahiro Yamazaki, Erik Wennerberg, Baldur Sveinbjørnsson, Øystein Rekdal, Sandra Demaria & Lorenzo Galluzzi. (2021) Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides. Trends in Cancer 7:6, pages 557-572.
Crossref
Crossref
Lorenzo Galluzzi & Abhishek D. Garg. (2021) Immunology of Cell Death in Cancer Immunotherapy. Cells 10:5, pages 1208.
Crossref
Crossref
Dhruv Bansal, Melissa A. Reimers, Eric M. Knoche & Russell K. Pachynski. (2021) Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer. Cancers 13:2, pages 334.
Crossref
Crossref
Jitka Fucikova, Radek Spisek, Guido Kroemer & Lorenzo Galluzzi. (2020) Calreticulin and cancer. Cell Research 31:1, pages 5-16.
Crossref
Crossref
Sajal Sen, Stephanie Hufnagel, Esther Y. Maier, Isaiah Aguilar, Jayaraman Selvakumar, Jennie E. DeVore, Vincent M. Lynch, Kuppuswamy Arumugam, Zhengrong Cui, Jonathan L. Sessler & Jonathan F. Arambula. (2020) Rationally Designed Redox-Active Au(I) N-Heterocyclic Carbene: An Immunogenic Cell Death Inducer. Journal of the American Chemical Society 142:49, pages 20536-20541.
Crossref
Crossref
Lorenzo Galluzzi, Juliette Humeau, Aitziber Buqué, Laurence Zitvogel & Guido Kroemer. (2020) Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nature Reviews Clinical Oncology 17:12, pages 725-741.
Crossref
Crossref
Huang-Yu Yang, Chao-Yi Wu, Jia-Jin Chen & Tao-Han Lee. (2020) Treatment Strategies and Metabolic Pathway Regulation in Urothelial Cell Carcinoma: A Comprehensive Review. International Journal of Molecular Sciences 21:23, pages 8993.
Crossref
Crossref
Jitka Fucikova, Oliver Kepp, Lenka Kasikova, Giulia Petroni, Takahiro Yamazaki, Peng Liu, Liwei Zhao, Radek Spisek, Guido Kroemer & Lorenzo Galluzzi. (2020) Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death & Disease 11:11.
Crossref
Crossref
Abhishek D. Garg & Patrizia Agostinis. (2020) Diversifying the platinum-based chemotherapy toolkit for immunogenic cancer cell death. Oncotarget 11:36, pages 3352-3353.
Crossref
Crossref
Zahra Asadzadeh, Elham Safarzadeh, Sahar Safaei, Ali Baradaran, Ali Mohammadi, Khalil Hajiasgharzadeh, Afshin Derakhshani, Antonella Argentiero, Nicola Silvestris & Behzad Baradaran. (2020) Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death. Cancers 12:4, pages 1047.
Crossref
Crossref